NZ546405A - Dry powder inhaler - Google Patents

Dry powder inhaler

Info

Publication number
NZ546405A
NZ546405A NZ546405A NZ54640504A NZ546405A NZ 546405 A NZ546405 A NZ 546405A NZ 546405 A NZ546405 A NZ 546405A NZ 54640504 A NZ54640504 A NZ 54640504A NZ 546405 A NZ546405 A NZ 546405A
Authority
NZ
New Zealand
Prior art keywords
inhaler
process according
pressure
fumarate dihydrate
dry powder
Prior art date
Application number
NZ546405A
Other languages
English (en)
Inventor
Magnus Olsson
Eva Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NZ546405A publication Critical patent/NZ546405A/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C71/00—After-treatment of articles without altering their shape; Apparatus therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0233—Conductive materials, e.g. antistatic coatings for spark prevention
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C2791/00—Shaping characteristics in general
    • B29C2791/004—Shaping under special conditions
    • B29C2791/006—Using vacuum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
NZ546405A 2003-10-07 2004-10-04 Dry powder inhaler NZ546405A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0302665A SE0302665D0 (sv) 2003-10-07 2003-10-07 Novel Process
PCT/GB2004/004202 WO2005035036A1 (en) 2003-10-07 2004-10-04 Dry powder inhaler

Publications (1)

Publication Number Publication Date
NZ546405A true NZ546405A (en) 2008-11-28

Family

ID=29398687

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ546405A NZ546405A (en) 2003-10-07 2004-10-04 Dry powder inhaler

Country Status (15)

Country Link
US (2) US7896005B2 (enExample)
EP (1) EP1680163A1 (enExample)
JP (1) JP4589928B2 (enExample)
KR (1) KR101110444B1 (enExample)
CN (2) CN1889991B (enExample)
AU (1) AU2004280109B2 (enExample)
BR (1) BRPI0415189A (enExample)
CA (1) CA2541374C (enExample)
IL (1) IL174735A (enExample)
MX (1) MXPA06003872A (enExample)
NO (1) NO336190B1 (enExample)
NZ (1) NZ546405A (enExample)
SE (1) SE0302665D0 (enExample)
WO (1) WO2005035036A1 (enExample)
ZA (1) ZA200602831B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1015883A3 (fr) * 2004-06-08 2005-10-04 Occhio Procede et dispositif de dispersion de poudres seches.
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CN102325532B (zh) 2008-10-07 2015-06-17 Mpex医药有限公司 用于减轻肺部炎症的左氧氟沙星吸入剂
AU2009302478B2 (en) 2008-10-07 2015-09-03 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
GB0912373D0 (en) 2009-07-16 2009-08-26 Innovata Biomed Ltd Improvements in or relating to dry powder inhalers
LT2473170T (lt) 2009-09-04 2019-10-10 Horizon Orphan Llc Aerozolizuoto levofloksacino panaudojimas cistinės fibrozės gydymui
GB201118188D0 (en) * 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
US11052202B2 (en) * 2012-11-07 2021-07-06 Chiesi Farmaceutici S.P.A. Drug delivery device for the treatment of patients with respiratory diseases
WO2015133909A1 (en) * 2014-03-03 2015-09-11 Nexus6 Limited A compliance monitor for a dry powder medicament delivery device
NO2709641T3 (enExample) 2014-03-10 2018-05-12
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
MX2018016046A (es) 2016-06-27 2019-05-02 Achillion Pharmaceuticals Inc Quinazolina y compuestos indol para tratar trastornos medicos.
CA3053818A1 (en) 2017-03-01 2018-09-07 Achillion Pharmaceuticals, Inc. Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
CN108771761B (zh) * 2018-08-16 2021-12-14 上海方予健康医药科技有限公司 一种糖皮质激素与β2受体激动剂的复方干粉吸入剂的制备工艺
EP3841086B1 (en) 2018-08-20 2025-04-23 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
CN113365617B (zh) 2018-10-16 2025-12-23 乔治亚州立大学研究基金会股份有限公司 用于医学疾病治疗的一氧化碳前药
MX2021011507A (es) 2019-03-22 2021-12-15 Achillion Pharmaceuticals Inc Compuestos farmaceuticos para el tratamiento de trastornos mediados por complemento.
CN114845708A (zh) 2019-12-19 2022-08-02 乔治亚州大学研究基金会 用于治疗细菌感染和增强抗生素的化合物
JP2023515073A (ja) 2020-02-20 2023-04-12 アキリオン ファーマシューティカルズ， インコーポレーテッド 補体因子ｄ媒介障害の処置用のヘテロアリール化合物
USD949321S1 (en) * 2020-05-29 2022-04-19 NuvoAir AB Housing for an add-on sensor for an inhaler
CA3193488A1 (en) 2020-09-23 2022-03-31 Jason Allan Wiles Pharmaceutical compounds for the treatment of complement mediated disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069715B1 (en) * 1981-07-08 1986-11-05 Aktiebolaget Draco Powder inhalator
SE9400257D0 (sv) * 1994-01-27 1994-01-27 Astra Ab Spacer
SE9400570D0 (sv) 1994-02-21 1994-02-21 Astra Ab Inhalation device, inhaler and processing unit
US6119853A (en) * 1998-12-18 2000-09-19 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
US6390291B1 (en) * 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6315112B1 (en) * 1998-12-18 2001-11-13 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
GB2353222B (en) * 1999-06-23 2001-09-19 Cambridge Consultants Inhalers
GB0107106D0 (en) 2001-03-21 2001-05-09 Boehringer Ingelheim Pharma Powder inhaler formulations
WO2003035028A1 (en) 2001-10-19 2003-05-01 Nektar Therapeutics Modulating charge density to produce improvements in the characteristics of spray-dried proteins
GB0130857D0 (en) * 2001-12-22 2002-02-06 Glaxo Group Ltd Medicament dispenser

Also Published As

Publication number Publication date
US7896005B2 (en) 2011-03-01
US20110056089A1 (en) 2011-03-10
KR101110444B1 (ko) 2012-02-17
IL174735A (en) 2010-12-30
BRPI0415189A (pt) 2006-11-28
NO20062065L (no) 2006-06-29
AU2004280109B2 (en) 2008-05-22
WO2005035036A1 (en) 2005-04-21
JP4589928B2 (ja) 2010-12-01
CA2541374A1 (en) 2005-04-21
JP2007507270A (ja) 2007-03-29
ZA200602831B (en) 2007-07-25
NO336190B1 (no) 2015-06-08
CA2541374C (en) 2013-05-14
MXPA06003872A (es) 2006-07-03
US8205611B2 (en) 2012-06-26
SE0302665D0 (sv) 2003-10-07
CN1889991B (zh) 2010-09-08
CN101856532A (zh) 2010-10-13
IL174735A0 (en) 2006-08-20
KR20060115728A (ko) 2006-11-09
US20070107721A1 (en) 2007-05-17
EP1680163A1 (en) 2006-07-19
AU2004280109A1 (en) 2005-04-21
CN1889991A (zh) 2007-01-03

Similar Documents

Publication Publication Date Title
US8205611B2 (en) Dry powder inhaler
US20230201489A1 (en) Dry powder drug delivery system and methods
Newman et al. Evolution of dry powder inhaler design, formulation, and performance
US20090250058A1 (en) Inhalation System and Delivery Device for the Administration of a Drug in the Form of Dry Powder
JPH08507704A (ja) 吸入装置
IL223742A (en) A dry powder inhaler and preparation for it
JP2007507270A5 (enExample)
JP2006511257A (ja) 医薬送達用システムに使用するための管状ノズル
CA2466448A1 (en) A medicament delivery assembly with a pulse valve
HK1210065B (en) Dry powder drug delivery systems

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 04 OCT 2017 BY CPA GLOBAL

Effective date: 20140903

Free format text: PATENT RENEWED FOR 7 YEARS UNTIL 04 OCT 2024 BY CPA GLOBAL

Effective date: 20140906

EXPY Patent expired